December 1, 2011

Pfizer's efforts to protect the sales of its blockbuster cholesterol drug Lipitor have attracted scrutiny from members of Congress, according to published reports.

October 21, 2011

Two senators are trying to get the Joint Select Committee on Deficit Reduction to take up a bill that would ban so-called "pay-for-delay" patent settlements between brand and generic drug companies, according to published reports.

September 26, 2010

For all its successes, the generic drug industry has had a lot to worry about...

September 9, 2010

This week’s decision by the U.S. Second Circuit Court of Appeals could make political efforts...